Cary Street Partners Financial LLC raised its stake in Stryker Corporation (NYSE:SYK – Free Report) by 26.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 9,865 shares of the medical technology company’s stock after purchasing an additional 2,045 shares during the quarter. Cary Street Partners Financial LLC’s holdings in Stryker were worth $3,467,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in SYK. Czech National Bank boosted its stake in shares of Stryker by 3.9% in the 4th quarter. Czech National Bank now owns 90,755 shares of the medical technology company’s stock valued at $31,898,000 after purchasing an additional 3,366 shares in the last quarter. Davis R M Inc. lifted its stake in Stryker by 1.8% in the third quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock worth $51,285,000 after purchasing an additional 2,512 shares during the last quarter. Terra Alpha Investments LLC purchased a new stake in Stryker during the third quarter valued at about $1,216,000. Kepler Cheuvreux Suisse SA bought a new position in shares of Stryker during the third quarter valued at about $27,952,000. Finally, Daymark Wealth Partners LLC increased its holdings in shares of Stryker by 436.0% in the fourth quarter. Daymark Wealth Partners LLC now owns 45,863 shares of the medical technology company’s stock worth $16,119,000 after buying an additional 37,307 shares during the period. 77.09% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts recently weighed in on SYK shares. Leerink Partners initiated coverage on Stryker in a report on Monday, April 13th. They set an “outperform” rating and a $410.00 target price for the company. Sanford C. Bernstein set a $410.00 price objective on Stryker in a research report on Friday, May 1st. Truist Financial restated a “hold” rating and issued a $330.00 target price (down from $380.00) on shares of Stryker in a report on Monday, May 4th. Barclays decreased their target price on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Finally, BTIG Research dropped their price target on shares of Stryker from $397.00 to $379.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $395.48.
Stryker Price Performance
Shares of SYK stock opened at $306.16 on Thursday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The firm has a market cap of $117.37 billion, a P/E ratio of 35.44, a P/E/G ratio of 1.97 and a beta of 0.80. The business’s 50 day moving average price is $323.45 and its 200-day moving average price is $348.79. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87.
Stryker (NYSE:SYK – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current year.
Stryker Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s payout ratio is presently 40.74%.
Insider Activity
In related news, VP M Kathryn Fink sold 5,220 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.85, for a total value of $1,481,697.00. Following the completion of the transaction, the vice president directly owned 13,137 shares of the company’s stock, valued at $3,728,937.45. This represents a 28.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 4.60% of the stock is owned by corporate insiders.
Stryker Profile
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
Featured Articles
- Five stocks we like better than Stryker
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
